title: Neoadjuvant treatment of adenocarcinomas of the gastroesophageal junction and stomach - a feasibility trial combining cisplatin and docetaxel with either 5-fluorouracil or capecitabine.
authors.affiliation: Department of Hematology and Oncology, University of Bochum, Marienhospital Herne, Herne, Germany.
authors.forename: B
authors.initials: B
authors.lastname: Schultheis
authors.forename: J
authors.initials: J
authors.lastname: Riebeling
authors.forename: M
authors.initials: M
authors.lastname: Allali
authors.forename: U
authors.initials: U
authors.lastname: Bergmann
authors.forename: G
authors.initials: G
authors.lastname: Kummer
authors.forename: U
authors.initials: U
authors.lastname: Sendler
authors.forename: A
authors.initials: A
authors.lastname: Tannapfel
authors.forename: A
authors.initials: A
authors.lastname: Sendler
authors.forename: D
authors.initials: D
authors.lastname: Strumberg
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy*; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D000069287:Capecitabine; D002945:Cisplatin / Q000008:administration & dosage; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D000077143:Docetaxel; D004938:Esophageal Neoplasms / Q000188:drug therapy*; D004943:Esophagogastric Junction; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage / Q000031:analogs & derivatives; D006801:Humans; D008297:Male; D008875:Middle Aged; D020360:Neoadjuvant Therapy; D013274:Stomach Neoplasms / Q000188:drug therapy*; D043823:Taxoids / Q000008:administration & dosage
chemical_list: D043823:Taxoids; D003841:Deoxycytidine; D000077143:Docetaxel; D000069287:Capecitabine; D002945:Cisplatin; D005472:Fluorouracil